Profound Medical Corp. logo
Profound Medical Corp. PROF
$ 7.24 -0.55%

Annual report 2023
added 12-21-2024

report update icon

Profound Medical Corp. Balance Sheet 2011-2024 | PROF

Annual Balance Sheet Profound Medical Corp.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - -7.36 M -18.7 M -5.96 M -10.6 M -3.37 M 1.31 M - - -

Long Term Debt

- - - - 6.72 M 10.6 M 444 K 2.8 M 4.01 M 1.95 M - - -

Long Term Debt Current

259 K 239 K 250 K 312 K 199 K - - - - - - - -

Total Non Current Liabilities

- - - 2.44 M 9.69 M 12 M 3.01 M 2.91 M 4.29 M - - - -

Total Current Liabilities

- - - - - - - - - - - - -

Total Liabilities

12.7 M 12.4 M 6.16 M 7.25 M - - 13.7 M 6.59 M 5.21 M 103 K - - -

Deferred Revenue

- - - 358 K 655 K 313 K 241 K 193 K - - - - -

Retained Earnings

- - - -130 M -131 M -111 M -90.3 M -53.2 M -39.7 M -453 K - - -

Total Assets

43.9 M 64.4 M 86.8 M 105 M - - 27.9 M 17.6 M 15.3 M 1.47 M - - -

Cash and Cash Equivalents

26.2 M 46.5 M 67.2 M 83.9 M 14.8 M - - - - - - - -

Book Value

31.2 M 52 M 80.6 M 97.4 M - - 14.1 M 11 M 10.1 M 1.37 M - - -

Total Shareholders Equity

- - - 97.4 M 14.4 M - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Profound Medical Corp.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 1.13 M - - - 1.36 M - - - 1.64 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 6.16 M - - - 7.25 M - - - 15.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -161 M - - - -130 M - - - -108 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 86.8 M - - - 105 M - - - 30.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 67.2 M - - - 83.9 M - - - 14.8 M - - - 22.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 80.6 M - - - 97.4 M - - - 14.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 80.6 M - - - 97.4 M - - - 14.4 M - - - 19.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency